ECG247 Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.95M

  • Investors
  • 3

ECG247 General Information

Description

Developer of a medically certified wireless heart rate sensor designed to monitor the heart rhythm for cardiac disorders investigation. The company offers an affordable and wireless heart rate sensor, resistant to water, with automatic interpretation and immediate results, that can be used both for self-testing and in collaboration with a doctor, enabling individuals and healthcare professionals to monitor heart rate for extended periods and prevent serious complications such as stroke and heart failure.

Contact Information

Website
www.ecg247.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Senterveien 30
  • 4790 Lillesand
  • Norway
+47
Primary Industry
Monitoring Equipment
Vertical(s)
Manufacturing, Digital Health, HealthTech
Corporate Office
  • Senterveien 30
  • 4790 Lillesand
  • Norway
+47

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ECG247 Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 01-Mar-2023 $1.95M Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view ECG247’s complete valuation and funding history, request access »

ECG247 Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • Pending

  • Expiring in next 12 mo

ECG247 Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4093287-A1 Method, device and system for wireless biopotential measurement Active 24-Jan-2020
EP-4093287-A4 Method, device and system for wireless biopotential measurement Active 24-Jan-2020
EP-4093287-B1 Method, device and system for wireless biopotential measurement Active 24-Jan-2020
US-20230112011-A1 Method, device and system for wireless biopotential measurement Inactive 24-Jan-2020
WO-2021150122-A1 Method, device and system for wireless biopotential measurement Inactive 24-Jan-2020 A61B5/6833
To view ECG247’s complete patent history, request access »

ECG247 Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ECG247 Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Skagerak Capital Venture Capital Minority
Health&Biotech Accelerator Accelerator/Incubator
To view ECG247’s complete investors history, request access »

Ready to get started?

Request a free trial

ECG247 FAQs

  • When was ECG247 founded?

    ECG247 was founded in 2017.

  • Where is ECG247 headquartered?

    ECG247 is headquartered in Lillesand, Norway.

  • What is the size of ECG247?

    ECG247 has 8 total employees.

  • What industry is ECG247 in?

    ECG247’s primary industry is Monitoring Equipment.

  • Is ECG247 a private or public company?

    ECG247 is a Private company.

  • What is the current valuation of ECG247?

    The current valuation of ECG247 is .

  • What is ECG247’s current revenue?

    The current revenue for ECG247 is .

  • How much funding has ECG247 raised over time?

    ECG247 has raised $1.95M.

  • Who are ECG247’s investors?

    , Skagerak Capital, and Health&Biotech Accelerator have invested in ECG247.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process